Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

FENNEC PHARMACEUTICALS INC. Director's Dealing 2019

Nov 14, 2019

35599_dirs_2019-11-14_77447f9e-d430-49c8-b4d6-aa89659c41c1.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: FENNEC PHARMACEUTICALS INC. (FENC)
CIK: 0001211583
Period of Report: 2019-11-13

Reporting Person: Cook Jodi A (Director)

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option (right to buy) $5.40 2029-11-13 Common shares (20000) Direct

Footnotes

F1: On November 13, 2019, Jodi A. Cook was granted an incentive stock option to purchase 20,000 shares of the Issuer's common shares pursuant to the Issuer's Amended and Restated Stock Option Plan. 100% of the shares under this option were fully vested as of the grant date.